Nicki Minaj made a surprise appearance at Turning Point USA’s AmericaFest on Sunday in Phoenix alongside Erika Kirk, the widow of TPUSA founder Charlie Kirk and the organization’s CEO. The pair ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

NEW YORK/LONDON, Nov 17 (Reuters) - U.S. oil major Chevron (CVX.N), opens new tab is studying options to buy global assets of sanctioned Russian oil firm Lukoil (LKOH.MM), opens new tab, five sources ...

The Justice Department on Thursday sued to block new congressional district boundaries approved by California voters last week, joining a court battle that could help determine which party wins ...

WASHINGTON—Syria has joined the U.S.-led mission to defeat Islamic State, U.S. officials said, after President Trump and Syrian President Ahmed al-Sharaa met at the White House on Monday. The move ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...